Our news
- 18/07/2019: Pharegis implemented optimized procedures for state registration of pharmaceuticals in Eurasian Economic Union.
- 20/06/2019: Pharegis updated timelines and practical approaches for Russian and EEU GMP inspection applications and procedures.
- 03/04/2019: Renewed general monographs of Russian state pharmacopeia XIV ed. have been analyzed.
Global industry news
Feed not found.
Contact us
Activities
Regulatory Events Russia
Russian Regulatory News
Regulatory news
Drugs.com - New Drug Approvals
- FDA Approves Jesduvroq (daprodustat) for Anemia Caused by Chronic Kidney Disease for Adults on Dialysis
- FDA Approves Orserdu (elacestrant) for Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast Cancer
- FDA Approves Jaypirca (pirtobrutinib) for Adult Patients with Relapsed or Refractory Mantle Cell Lymphoma
- FDA Approves Brenzavvy (bexagliflozin) for the Treatment of Adults with Type 2 Diabetes
- Brukinsa (zanubrutinib) Approved in the U.S. for Chronic Lymphocytic Leukemia
News and press releases
- EMA update on shortages of antibiotics in the EU, , 26/01/2023
- Actions to support the development of medicines for children, PDCO, 06/02/2023
- Public consultation on a multi-stakeholder platform to improve clinical trials in the EU, , 03/02/2023
- EMA Committee on Herbal Medicinal Products re-elects Emiel van Galen as Chair, HMPC, 03/02/2023
Drugs.com - Clinical Trials
- Wellmarker Bio Announces Clinical Trial Collaboration with MSD to evaluate WM-A1-3389 in combination with KEYTRUDA SEOUL, South Korea , Feb. 7,...
- Results in Phase 2 scleroderma study by Certa Therapeutics demonstrates improvement in more than 60% of patients MELBOURNE, Australia, Feb....
- New Publication Validates SeptiCyte RAPID as a Triaging Tool for COVID-19 Patients SEATTLE and BRISBANE,...
- Ionis announces GSK has advanced bepirovirsen into Phase 3 development CARLSBAD, Calif., Feb. 1,...